MENU

Prof. Magi at the cfDNA Day in Rome

At Oxford Nanopore cfDNA day, Prof. Magi presented his group's research on liquid biopsy in colorectal cancer.

Prof. Magi at the cfDNA Day in Rome

On July 2nd, 2026, Rome hosted the cfDNA Day, a specialized international seminar organized by Oxford Nanopore Technologies. The event brought together leading clinicians and researchers from across Europe to discuss the latest technological and computational breakthroughs in cell-free DNA (cfDNA) analysis.

The seminar, held at the Aula Passariello (Sapienza University of Rome), served as a vital hub for experts dedicated to pushing the boundaries of non-invasive diagnostics. With cfDNA profiling rapidly becoming a cornerstone of modern oncology, the event focused on how real-time, long-read sequencing can overcome the limitations of traditional molecular methods.

Our research group took center stage during this event, with Prof. Alberto Magi delivering an invited talk titled: "Integrated chromatin and methylation profiling of cfDNA in colorectal cancer using Nanopore sequencing". During his presentation, Prof. Magi showcased the laboratory's latest computational advancements in third-generation sequencing data analysis. He demonstrated how Nanopore technology allows researchers to extract multi-omic layers of information, i.e.  genetic alterations, chromatin accessibility, and epigenetic methylation patterns, from a single sequencing run of liquid biopsy samples. In particular Prof.. Magi introduced the Window Protection Score (WPS), a quantitative measure of nucleosome protection from cfDNA fragment ends patterns, and the Window Protection Ratio (WPR), a normalized metric of nucleosome protection in cfDNA.

This integrated approach could offers unprecedented accuracy in tracking tumor dynamics and identifying biomarkers critical for colorectal cancer progression.

 

06 July 2026

 

Cookies

I cookie di questo sito servono al suo corretto funzionamento e non raccolgono alcuna tua informazione personale. Se navighi su di esso accetti la loro presenza.  Maggiori informazioni